Tag Archives: genetics

November, 2018

1 November
23andMe Granted the First and Only FDA Authorization For Direct-to-Consumer Pharmacogenetic Reports

Mountain View, California – October 31, 2018 – In another first, the U.S. Food and Drug Administration (FDA) granted 23andMe de novo authorization to offer reports on pharmacogenetics, indicating how customers’ genetics may influence the way they metabolize certain medications. This is the first authorization of a direct-to-consumer report on pharmacogenetics, and came …
Share

30 August
Vertex and Genomics plc Collaborate to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines

BOSTON & OXFORD, United Kingdom–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Genomics plc today announced a three-year collaboration, extendable to five years, to use human genetics and machine learning to improve discovery of targets for precision medicines, and to advance understanding of the clinical impact of human genetic variation and …
Share

11 November
Illumina and Mayo Clinic Form Bioinformatics Relationship to Advance Genetic Disorder Testing

SAN DIEGO & ROCHESTER, Minn.–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo’s delivery of genetic and genomic expertise. Together, the organizations plan to integrate existing services and software tools and …
Share

20 June
Researchers Discover Potentially Pathogenic Bacterium in Children with Acute Leukemia

BOSTON, June 20, 2016 /PRNewswire/ — Researchers at the Human Microbiology Institute (HMI) have discovered a novel bacteria in the saliva of children with acute leukemia that they say could be linked to deadly, drug-resistant pneumonia in patients with blood cancer. In an abstract presented over the weekend at ASM …
Share
15 June
New Genetic Research Can Significantly Improve Drug Development

With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars? According to a new study published in the International Journal of Epidemiology this week, genetic research …
Share